Composition comprising 5-¬4-¬2-(n-methyl-n-2-pyridyl)amino)ethoxy benzyl thiazolidine-2,4-dione
CA 2333352 A1 · Owner: Wray, Paul Nigel · Inventors: Wray, Paul Nigel; Ross, Hamish; Granett, Jeffrey Roger
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A pharmaceutical composition comprising Compound (I) characterised in that , the, composition comprises 2 to 12 mg of Compound (I) in a pharmaceutically acceptable, form and optionally a pharmaceutically acceptable carrier therefor the use of , such a, composition in medicine processed for the preparation of such a composition and, intermediate composition useful in such a process.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 2, 1998. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended June 2, 2018.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 2, 2020.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.